Amyloid Fibrils: the Eighth Wonder of the World in Protein Folding and Aggregation  by Lednev, Igor K.
Biophysical Journal Volume 106 April 2014 1433–1435 1433New and Notable
Amyloid Fibrils: the Eighth
Wonder of the World in Protein
Folding and Aggregation
Igor K. Lednev*
Department of Chemistry, University at
Albany, State University of New York,
Albany, New York
Protein folding, misfolding, and aggre-
gation are among the central topics of
molecular biology in the postgenome
era. Increasing evidence indicates that
protein aggregation plays a vital role
in a variety of biological processes.
Specifically, fibrillar aggregates, i.e.,
filamentous assemblies of peptides
and proteins that possess a common
cross-b sheet structure, have been
found in a wide range of organisms,
from bacteria to mammals, and have
been shown to possess different phy-
siological functions. However, the
extensive research on fibrillar aggre-
gates has primarily been driven by the
fact that some of these aggregates,
known as amyloid fibrils, are found as
deposits in the tissues and organs of pa-
tients diagnosed with various amyloid-
associated diseases such asAlzheimer’s
disease, Parkinson’s disease, Hunting-
ton’s disease, prion disease, type-2
diabetes, etc. (1). These maladies can
be sporadic, inherited, or even infec-
tious, and misfolded protein aggregates
are often considered biomedical
markers of these diseases. Despite great
interest, a full understanding of the
causes of these diseases and the roles
of protein oligomers and fibrils has not
yet been achieved. According to one
hypothesis, an abnormally high local
protein concentration in multivesicular
bodies results in protein aggregation.
These prefibrillar aggregates cause
cell death and the release of toxic spe-
cies into the extracellular space. Inhttp://dx.doi.org/10.1016/j.bpj.2014.02.007
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fibrils is considered a defense mecha-
nism, which nature uses to clear these
toxic oligomers from the cell media.
Therefore, prefibrillar oligomers rather
than mature fibrils are thought to be
responsible for the progression of
neurodegenerative diseases.
Significant knowledge regarding the
in vitro formation and structure of
amyloid fibrils has been accumulated
over the past 60 years. Based on kinetic
studies of fibrillation, several mecha-
nisms for this process have been
proposed. It is well accepted that
fibrillation begins with a thermo-
dynamically unfavorable nucleation
step, followed by the rapid elongation
of fibrils (2). An understanding of
the nucleation mechanism is crucial
for developing inhibitors for the
limiting stage of the pathological pro-
cess. Thus far, the proposed nucleation
models have been primarily verified by
correlations between the fibrillation
lag-time or the rate of fibril accumu-
lation and protein concentrations
or other experimental conditions,
although direct detection of the fibrilla-
tion nucleus has been also reported
(3). According to the thermodynamic
nucleus model for homogeneous
nucleation, the nucleus is defined as a
metastable species, the formation of
which determines the lag-phase of
fibrillation.
At first glance, various proteins form
fibrillar aggregates with similar mor-
phologies (elongated, unbranched)
and a common cross-b sheet structure,
despite differences in the proteins’ pri-
mary sequences, native structures, and
physiological activities. However, a
more detailed analysis reveals a great
variety exhibiting subtle changes in
the shape, size, and structure of amy-
loid fibrils, as well as the fibrillation
kinetics, depending on the protein
sequence (2). In a recent Biophysical
Journal article (4), a collaboration
between three well-established labora-
tories in the field, headed by Raleigh,
Zanni, and Serrano, demonstrated
that mutations cause a great deal ofvariation in the fibrillation of islet
amyloid polypeptides (IAPPs or Amy-
lin). IAPP is a pancreatic hormone
that is cosecreted with insulin and
forms islet amyloid in type-2 diabetes
and leads to b-cell dysfunction and
cell death. The formation of islet
amyloid is also thought to significantly
contribute to the failure of islet cell
transplants. Despite its importance,
islet amyloid formation is not yet
well understood. The authors investi-
gated the role of the C-terminus of
IAPP, particularly the interaction of
Tyr-37 with His-18, during amyloid
formation to evaluate a number of
hypothetical mechanisms reported in
the literature for early oligomerization
of IAPP.
Previous NMR studies proposed the
formation of a head-to-tail IAPP dimer
generated by stacking of the side
chains of His-18 and Tyr-37. However,
this model was developed based on an
IAPP variant with a free C-terminus at
low pH. New data reported by Tu et al.
(4) indicate that even if such inter-
actions occur in the physiologically
relevant amidated form of IAPP (at
physiological pH), they do not promote
amyloid formation. Seeding experi-
ments were used to investigate the
structural similarity and dissimilarity
between fibrils prepared from different
IAPP variants, including those with an
amide group at the C-terminus re-
placed with a carboxylate and His-18
replaced with the neutral residues Gln
or Leu. The obtained results illustrated
the importance of the C-terminus and
strongly suggest the presence of differ-
ences in the fibril structure formed
by amidated and unamidated IAPP.
Thus, one may wonder that simply re-
placing an amide group at the C-termi-
nus with a carboxylate would be more
effective than replacing His-18 with
residues that differ significantly in
shape and polarity (4).
It has been well documented in the
literature that changing the state of
1434 Lednevdisulfide bonds in proteins by reduc-
tion or methylation results in sig-
nificant variations in the aggregation
kinetics, as well as the structure and
morphology of the resultant fibrils. It
is thought that disulfide bonds limit
the manner in which a protein can
aggregate into a fibril via steric re-
straint. From this perspective, a recent
study of disulfide bond behavior during
insulin fibrillation revealed somewhat
unexpected results (5). All three disul-
fide bonds of native insulin remained
intact during the aggregation process,
withstanding scrambling. Moreover,
the predominant gauche-gauche-
gauche (g-g-g) conformation of the
C-C-S-S-C-C segment is identical for
all disulfide bonds in fibrils and the
native protein, as evident from Raman
spectroscopic measurements. The pos-
sibility of preserving disulfide bonds in
their original conformation despite sig-
nificant structural rearrangements of
the protein during the fibrillation pro-
cess was illustrated by all-atom molec-
ular-dynamic simulations.
In addition to the protein sequence,
variations in aggregation conditions
often result in significant changes in
fibrils, a phenomenon known as ‘‘fibril
polymorphism’’. This display of func-
tional and structural heterogeneity in
amyloid fibrils is particularly impor-
tant because different polymorphs
often exhibit different biological activ-
ity and associated toxicity. Surpris-
ingly small changes in conditions can
generate different fibril polymorphs
from the same protein. For example,
two amyloid states with distinct mor-
phologies were prepared under iden-
tical solvent conditions but with
different shaking modes using the
same pool of highly pure, full-length
Syrian hamster recombinant prion
protein (6). The cross-b cores of these
polymorphs exhibited similar crystal-
line-like structures, but the interstrand
hydrogen bonds were of different
strengths.
According to a 2012 article in
Biophysical Journal (7), an increase
in the solution pH by only one unit dur-
ing the aggregation process results inBiophysical Journal 106(7) 1433–1435significant variations in the mor-
phology of insulin fibrils. Tapelike
individual and binary fibrils form at
pH 1.5 whereas insulin fibrils with a
strong left-handed twist dominate at
pH 2.5. Unexpectedly, these distinct
fibril polymorphs displayed opposing
supramolecular chiralities, as deter-
mined by vibrational circular dichro-
ism (VCD) measurements (7). VCD
supramolecular chirality is correlated
with the apparent fibril handedness
and provides a sense of chirality from
a deeper level of chiral organization,
at the protofilament level of the fibril
structure. Specifically, normal VCD
fibrils have a left-handed twist,
whereas reversed VCD fibrils are flat-
like aggregates with no obvious helical
twist, as evident from atomic force and
scanning electron microscopy.
Although the vast majority of accu-
mulated knowledge is associated with
either bulk (overall) fibrils or fibril
core structures, the fibril surface is ex-
pected to play a significant role in am-
yloid biological activity and toxicity.
Tip-enhanced Raman spectroscopy is
uniquely suitable for structural charac-
terization of the fibril surface. The sur-
faces of two insulin fibril polymorphs
with tapelike and left-handed twist
morphology (as mentioned above)
were observed by tip-enhanced Raman
spectroscopy to differ substantially in
both amino-acid composition and
protein secondary structure (8). The
amounts of Tyr, Pro, and His differ, as
does the number of carboxyl groups
on the respective surfaces, whereas
the amounts of Phe and of positively
charged amino and imino groups
remain similar. In addition, the surfaces
of protofilaments, the precursors of
mature fibrils, exhibit substantial dif-
ferences with respect to mature fibrils.
It is well accepted that amyloid
fibrils are extraordinarily stable and
represent the most energetically favor-
able form of proteins. Typically, harsh
denaturing conditions are required to
dis-integrate fibrils prepared from
full-length proteins, and further fibril-
lation is not expected to occur under
these conditions. We recently discov-ered that mild temperature and salinity
variations result in substantial melting
of the fibril core of mature apo-a-lact-
albumin fibrils and spontaneous refold-
ing into a different fibril polymorph
(9). This spontaneous refolding, which
occurs without the disintegration of
individual fibrils, has potential disease
relevance and is of fundamental signif-
icance to biology in general as a
‘‘new type of protein folding-aggrega-
tion phenomenon’’ (9). Understanding
the mechanism of this process could
allow regulation of the biological
activity of fibrils and their associated
toxicity. Spontaneous refolding is not
limited to a single amyloid system or
one type of solution change. A small
pH change can initiate the spontaneous
transformation of insulin fibrils from
one polymorph to another, resulting
in switching of fibril supramolecular
chirality along with both morpholog-
ical and structural changes (10).
This brief commentary merely
scratches the surface of the broad and
intriguing field of amyloid fibrillation.
The main goal of this commentary is
to illustrate the great variety of factors
affecting amyloid morphology, pro-
perties, and formation mechanisms.
Inspired by recent advances in the
field, as exemplified by the exciting
work of Tu et al. (4), who demon-
strated the significant consequences
of Amylin sequence variations, re-
searchers have found many solution
factors that affect in vitro fibrillation.
Although significant knowledge about
amyloid fibrils has accumulated over
the past 60 years, further study is
required to improve our understanding
of the biophysics of the fibrillation pro-
cess to predict fibril structure and prop-
erties based on the underlying protein
sequence and aggregation conditions.
The great importance of amyloid
fibrils for biology and medicine and
the multitude of fibril variations in
response to changes in conditions and
protein sequences make us wonder.This project is supported by award No.
R01AG033719 from the National Institutes of
Health.
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